FABP3 and acute coronary syndrome: Given the limited availability of H-FABP, Body et al. [63] performed secondary analyses on four prospective datasets to re-derive and re-validate a version of MACS without H-FABP, with the new tool termed the Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid.